US Stock MarketDetailed Quotes

Biodesix (BDSX)

Watchlist
  • 13.310
  • +0.650+5.13%
Close Apr 16 16:00 ET
  • 13.050
  • -0.260-1.95%
Post 19:22 ET
134.53MMarket Cap-2.85P/E (TTM)

Biodesix (BDSX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
24.08%88.5M
40.76%28.76M
19.93%21.77M
11.68%20.02M
21.19%17.96M
45.30%71.32M
39.28%20.43M
34.54%18.15M
50.99%17.93M
63.63%14.82M
Operating revenue
24.08%88.5M
40.76%28.76M
19.93%21.77M
11.68%20.02M
21.19%17.96M
45.30%71.32M
39.28%20.43M
34.54%18.15M
50.99%17.93M
63.63%14.82M
Cost of revenue
7.36%16.72M
12.37%4.88M
-1.75%4.11M
3.97%4.03M
16.63%3.7M
19.70%15.57M
28.69%4.34M
29.42%4.18M
19.73%3.88M
0.19%3.18M
Gross profit
28.75%71.78M
48.42%23.88M
26.41%17.66M
13.80%15.99M
22.43%14.26M
54.53%55.75M
42.44%16.09M
36.15%13.97M
62.71%14.05M
97.77%11.64M
Operating expense
10.59%99.55M
14.18%25.84M
9.50%24.71M
15.58%25.68M
3.20%23.32M
16.33%90.01M
24.77%22.63M
29.42%22.56M
13.58%22.22M
1.60%22.6M
Selling and administrative expenses
8.82%87.55M
13.62%22.97M
8.48%21.71M
13.99%22.41M
-0.53%20.45M
19.39%80.45M
24.42%20.22M
29.17%20.02M
18.07%19.66M
8.25%20.56M
Research and development costs
25.55%12M
18.89%2.87M
17.47%2.99M
27.80%3.27M
40.69%2.87M
-4.30%9.56M
27.79%2.41M
31.42%2.55M
-12.10%2.56M
-37.25%2.04M
Operating profit
18.96%-27.77M
69.97%-1.97M
18.01%-7.04M
-18.64%-9.69M
17.26%-9.06M
17.04%-34.26M
4.38%-6.55M
-19.79%-8.59M
25.23%-8.17M
33.02%-10.95M
Net non-operating interest income expense
6.56%-7.72M
-17.52%-2.06M
-1.62%-2.07M
1.96%-1.9M
33.37%-1.69M
13.40%-8.26M
24.77%-1.75M
14.46%-2.04M
20.33%-1.94M
-5.77%-2.53M
Non-operating interest expense
-6.56%7.72M
17.52%2.06M
1.62%2.07M
-1.96%1.9M
-33.37%1.69M
-13.40%8.26M
-24.77%1.75M
-14.46%2.04M
-20.33%1.94M
5.77%2.53M
Other net income (expense)
152.54%217K
-4.26%45K
7.49%402K
117.52%123K
-167.42%-353K
68.52%-413K
30.56%47K
126.89%374K
-70,300.00%-702K
-414.29%-132K
Gain on sale of security
---280K
--0
----
--98K
---378K
----
----
----
----
----
Special income (charges)
77.98%-107K
99.03%-1K
---7K
91.75%-26K
-7.35%-73K
-1,004.55%-486K
-329.17%-103K
--0
---315K
-240.00%-68K
-Less:Impairment of capital assets
-55.04%107K
-99.03%1K
--7K
-61.19%26K
7.35%73K
440.91%238K
329.17%103K
--0
--67K
240.00%68K
-Less:Other special charges
----
----
----
----
----
--248K
--0
----
--248K
----
Other non- operating income (expenses)
727.40%604K
-69.33%46K
9.36%409K
113.18%51K
253.13%98K
1,116.67%73K
7,400.00%150K
18,600.00%374K
-38,800.00%-387K
-6,500.00%-64K
Income before tax
17.86%-35.27M
51.76%-3.98M
15.03%-8.72M
-6.11%-11.47M
18.46%-11.1M
17.67%-42.93M
9.72%-8.25M
6.31%-10.26M
19.08%-10.81M
27.21%-13.61M
Income tax
Net income
17.86%-35.27M
51.76%-3.98M
15.03%-8.72M
-6.11%-11.47M
18.46%-11.1M
17.67%-42.93M
9.72%-8.25M
6.31%-10.26M
19.08%-10.81M
27.21%-13.61M
Net income continuous Operations
17.86%-35.27M
51.76%-3.98M
15.03%-8.72M
-6.11%-11.47M
18.46%-11.1M
17.67%-42.93M
9.72%-8.25M
6.31%-10.26M
19.08%-10.81M
27.21%-13.61M
Minority interest income
Net income attributable to the parent company
17.86%-35.27M
51.76%-3.98M
15.03%-8.72M
-6.11%-11.47M
18.46%-11.1M
17.67%-42.93M
9.72%-8.25M
6.31%-10.26M
19.08%-10.81M
27.21%-13.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
17.86%-35.27M
51.76%-3.98M
15.03%-8.72M
-6.11%-11.47M
18.46%-11.1M
17.67%-42.93M
9.72%-8.25M
6.31%-10.26M
19.08%-10.81M
27.21%-13.61M
Basic earnings per share
29.67%-4.67
59.17%-0.49
17.14%-1.16
0.00%-1.6
42.86%-1.6
48.13%-6.64
40.00%-1.2
50.00%-1.4
52.94%-1.6
41.67%-2.8
Diluted earnings per share
29.67%-4.67
59.17%-0.49
17.14%-1.16
0.00%-1.6
42.86%-1.6
48.13%-6.64
40.00%-1.2
50.00%-1.4
52.94%-1.6
41.67%-2.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 24.08%88.5M40.76%28.76M19.93%21.77M11.68%20.02M21.19%17.96M45.30%71.32M39.28%20.43M34.54%18.15M50.99%17.93M63.63%14.82M
Operating revenue 24.08%88.5M40.76%28.76M19.93%21.77M11.68%20.02M21.19%17.96M45.30%71.32M39.28%20.43M34.54%18.15M50.99%17.93M63.63%14.82M
Cost of revenue 7.36%16.72M12.37%4.88M-1.75%4.11M3.97%4.03M16.63%3.7M19.70%15.57M28.69%4.34M29.42%4.18M19.73%3.88M0.19%3.18M
Gross profit 28.75%71.78M48.42%23.88M26.41%17.66M13.80%15.99M22.43%14.26M54.53%55.75M42.44%16.09M36.15%13.97M62.71%14.05M97.77%11.64M
Operating expense 10.59%99.55M14.18%25.84M9.50%24.71M15.58%25.68M3.20%23.32M16.33%90.01M24.77%22.63M29.42%22.56M13.58%22.22M1.60%22.6M
Selling and administrative expenses 8.82%87.55M13.62%22.97M8.48%21.71M13.99%22.41M-0.53%20.45M19.39%80.45M24.42%20.22M29.17%20.02M18.07%19.66M8.25%20.56M
Research and development costs 25.55%12M18.89%2.87M17.47%2.99M27.80%3.27M40.69%2.87M-4.30%9.56M27.79%2.41M31.42%2.55M-12.10%2.56M-37.25%2.04M
Operating profit 18.96%-27.77M69.97%-1.97M18.01%-7.04M-18.64%-9.69M17.26%-9.06M17.04%-34.26M4.38%-6.55M-19.79%-8.59M25.23%-8.17M33.02%-10.95M
Net non-operating interest income expense 6.56%-7.72M-17.52%-2.06M-1.62%-2.07M1.96%-1.9M33.37%-1.69M13.40%-8.26M24.77%-1.75M14.46%-2.04M20.33%-1.94M-5.77%-2.53M
Non-operating interest expense -6.56%7.72M17.52%2.06M1.62%2.07M-1.96%1.9M-33.37%1.69M-13.40%8.26M-24.77%1.75M-14.46%2.04M-20.33%1.94M5.77%2.53M
Other net income (expense) 152.54%217K-4.26%45K7.49%402K117.52%123K-167.42%-353K68.52%-413K30.56%47K126.89%374K-70,300.00%-702K-414.29%-132K
Gain on sale of security ---280K--0------98K---378K--------------------
Special income (charges) 77.98%-107K99.03%-1K---7K91.75%-26K-7.35%-73K-1,004.55%-486K-329.17%-103K--0---315K-240.00%-68K
-Less:Impairment of capital assets -55.04%107K-99.03%1K--7K-61.19%26K7.35%73K440.91%238K329.17%103K--0--67K240.00%68K
-Less:Other special charges ----------------------248K--0------248K----
Other non- operating income (expenses) 727.40%604K-69.33%46K9.36%409K113.18%51K253.13%98K1,116.67%73K7,400.00%150K18,600.00%374K-38,800.00%-387K-6,500.00%-64K
Income before tax 17.86%-35.27M51.76%-3.98M15.03%-8.72M-6.11%-11.47M18.46%-11.1M17.67%-42.93M9.72%-8.25M6.31%-10.26M19.08%-10.81M27.21%-13.61M
Income tax
Net income 17.86%-35.27M51.76%-3.98M15.03%-8.72M-6.11%-11.47M18.46%-11.1M17.67%-42.93M9.72%-8.25M6.31%-10.26M19.08%-10.81M27.21%-13.61M
Net income continuous Operations 17.86%-35.27M51.76%-3.98M15.03%-8.72M-6.11%-11.47M18.46%-11.1M17.67%-42.93M9.72%-8.25M6.31%-10.26M19.08%-10.81M27.21%-13.61M
Minority interest income
Net income attributable to the parent company 17.86%-35.27M51.76%-3.98M15.03%-8.72M-6.11%-11.47M18.46%-11.1M17.67%-42.93M9.72%-8.25M6.31%-10.26M19.08%-10.81M27.21%-13.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 17.86%-35.27M51.76%-3.98M15.03%-8.72M-6.11%-11.47M18.46%-11.1M17.67%-42.93M9.72%-8.25M6.31%-10.26M19.08%-10.81M27.21%-13.61M
Basic earnings per share 29.67%-4.6759.17%-0.4917.14%-1.160.00%-1.642.86%-1.648.13%-6.6440.00%-1.250.00%-1.452.94%-1.641.67%-2.8
Diluted earnings per share 29.67%-4.6759.17%-0.4917.14%-1.160.00%-1.642.86%-1.648.13%-6.6440.00%-1.250.00%-1.452.94%-1.641.67%-2.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More